ConductScience.org, home

Cell line · CVCL_C9AM

SUM149R

Cancer cell line, Homo sapiens. Breast inflammatory carcinoma. 2 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. SUM149R. Cell lines, record CVCL_C9AM. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_C9AM

On this page

Cell line

As Cellosaurus gives it.

Name
SUM149R
Accession
CVCL_C9AM
RRID
RRID:CVCL_C9AM
Synonyms
SUM-149PT(R)
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
40Y
Category
Cancer cell line
Diseases
Breast inflammatory carcinoma (NCIt C4001); Inflammatory breast cancer (ORDO Orphanet_694963)
Derived from
Breast (in situ)
Parent
SUM149PT (CVCL_3422)
Entry created
2023-10-05
Entry updated
2026-03-31

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers2

PaperJournalYearHow we knowRetractedSource
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.Mol Cell2020Cellosaurus cites itPubMed
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.Nature2016Cellosaurus cites itPubMed

Relatives1

RelationCell lineAccessionProblem
ParentSUM149PTCVCL_3422

Source Cell lines

Cell banks0

None in this release.

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_C9AM

GET https://conductscience.org/api/cell-lines/v1/CVCL_C9AM/problems